𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clopidogrel dose-ranging phase II study in patients with athesclerotic disease

✍ Scribed by Bernard Boneu

Book ID
118585251
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
175 KB
Volume
27
Category
Article
ISSN
1558-3597

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Dose-ranging study of tolterodine in pat
Dose-ranging study of tolterodine in patients with detrusor hyperreflexia
✍ P.E.V.A. Van Kerrebroeck; G. Amarenco; J.W. ThΓΌroff; H.G. Madersbacher; M.T.W.T. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 69 KB

Tolterodine is a potent antimuscarinic agent specifically developed for the treatment of urinary urge incontinence and other symptoms related to the overactive bladder. In order to assess the optimum dosage for use in future clinical studies, a double-blind, randomized, placebo-controlled, parallel-

A phase II, randomized, double-blind, pl
A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus
✍ Wallace, Daniel J. ;Stohl, William ;Furie, Richard A. ;Lisse, Jeffrey R. ;McKay, πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 372 KB πŸ‘ 2 views

## Abstract ## Objective To assess the safety, tolerability, biologic activity, and efficacy of belimumab in combination with standard of care therapy (SOC) in patients with active systemic lupus erythematosus (SLE). ## Methods Patients with a Safety of Estrogens in Lupus Erythematosus: National